Generic Drugs Market - India
Market Statistics
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 28.06 Billion
Market Size in 2033: USD 51.47 Billion
Market Growth Rate (CAGR) 2025-2033: 6.97%
According to IMARC Group's report titled "India Generic Drugs Market Report and Forecast 2025-2033," the market reached USD28.06 billion in 2024. Looking forward, IMARC Group expects the market to reach USD 51.47 billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033.
Download sample copy of the Report: https://www.imarcgroup.com/india-generic-drugs-market/requestsample
India Generic Drugs Market Trends and Drivers:
The Indian generic drugs market is growing steadily, driven by affordability, a strong manufacturing base, and rising global and domestic healthcare demand.
Generic drugs, being cost-effective alternatives to branded medicines, are improving healthcare accessibility, especially in rural and underdeveloped areas.
India is globally recognized as the "pharmacy of the world" for supplying the highest share of generic medicines to both developed and developing nations.
The country benefits from compliance with global regulatory standards and enjoys a low-cost manufacturing advantage.
The growing prevalence of chronic diseases like diabetes, hypertension, and cardiovascular conditions has increased the demand for long-term medications, largely fulfilled through generics.
Government initiatives like the Jan Aushadhi Scheme and public procurement systems are enhancing the availability and accessibility of generic medicines at grassroots levels.
Rising healthcare insurance penetration and public health schemes are increasing the consumption of generics among hospitals and primary healthcare centers.
Patent expiries of high-value drugs in global markets are opening new export opportunities for Indian pharmaceutical firms.
Local awareness regarding the efficacy and safety of generic drugs is improving consumer confidence and boosting adoption.
The increasing number of FDA and WHO-GMP approved facilities is strengthening India's reputation as a global hub for generic drug manufacturing.
The growth of online pharmacies and e-health platforms is enabling last-mile delivery of generic medicines and encouraging competitive pricing.
Rising out-of-pocket healthcare expenditure and consumer frugality are prompting even urban populations to shift towards generic alternatives.
Government efforts to encourage doctors to prescribe generics are aligning policy and medical practices in favor of the market.
Strategic partnerships between Indian pharmaceutical companies and global players for contract manufacturing and bulk supply are contributing to market growth.
A combination of regulatory support, export opportunities, public health focus, and economic need for affordable treatments ensures long-term and inclusive growth of the Indian generic drug market.
India Generic Drugs Industry Segmentation:
We explore the factors propelling the India generic drugs market growth, including technological advancements, consumer behaviors, and regulatory changes.
Therapy Area Insights:
- Central Nervous System
- Cardiovascular
- Dermatology
- Genitourinary/Hormonal
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Drug Delivery Insights:
- Oral
- Injectables
- Dermal/Topical
- Inhalers
Distribution Channel Insights:
- Retail Pharmacies
- Hospital Pharmacies
Regional Insights:
- North India
- South India
- East India
- West India
Request for customization: https://www.imarcgroup.com/request?type=report&id=30695&flag=C
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
Comments